长非编码RNA在动脉硬度和高血压中的调控作用
Jose D Vargas1, Malak Abbas2, Gabriel Goodney3
1DC Veteran affairs Medical Center, Washington, DC (J.D.V.).
Hypertension (Dallas, Tex. : 1979)
|May 29, 2025
概括
长非编码RNAs (lncRNAs) 调节与动脉硬和高血压相关的基因. 这项研究确定了特定的lncRNA及其相关的信使RNA (mRNA),包括UCP2,为非裔美国人的心血管疾病机制提供了新的见解.
科学领域:
- 基因组学和分子生物学
- 心血管研究研究心血管研究
- 文字转录学 (Transcriptomics) 是一个学科.
背景情况:
- 通过脉冲波速度 (PWV) 测量的动脉硬是心血管疾病和高血压的关键风险因素.
- 非洲裔美国人患高血压的患病率不成比例.
- 长非编码RNAs (lncRNAs) 越来越多地被认为是它们在复杂疾病中的调节作用.
研究的目的:
- 研究 lncRNAs 在调节与动脉硬和高血压相关的信使RNAs (mRNAs) 中的调节作用.
- 在心血管健康的背景下识别特定的lncRNA-mRNA相互作用.
- 专注于非洲裔美国人,他们受到高血压的严重影响.
主要方法:
- 利用了来自两个非洲裔美国人队伍 (GENE-FORECAST和MH-GRID) 的全血转录组测序数据.
- 在高和低PWV组之间确定了差异表达的lncRNA和mRNA.
- 确定了lncRNA-mRNA关联,并将它们与高血压状态联系起来,并通过队列验证.
主要成果:
- 发现了1035个mRNA和31个lncRNA与PWV有关的差异表达.
- 确定了31个lncRNAs和1034个mRNAs之间的显著相互作用.
- 发现与高血压相关的22个lncRNA调节的mRNA,与UCP2表达相关的30个lncRNA.
结论:
- lncRNAs在调节与动脉硬和高血压相关的基因表达方面发挥着重要作用.
- 已确定的lncRNA-mRNA相互作用,特别是涉及UCP2,为动脉硬的分子机制提供了洞察力.
- 这些发现有助于了解非裔美国人高血压的遗传基础.
相关概念视频
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Neural Regulation of Blood Pressure
3.5K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
3.5K
Hypertension II: Pathophysiology
91
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
91
Hypertension and Regulation of Blood Pressure
3.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
913
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
913
Antihypertensive Drugs: Angiotensin II Receptor Blockers
950
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
950


